Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease

Paul N. Hopkins, Lily L. Wu, Steven Hunt, Brent C. James, G. Michael Vincent, Roger R. Williams

Research output: Contribution to journalArticle

289 Citations (Scopus)

Abstract

Mildly increased serum bilirubin has recently been suggested as aa protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9±6.1 μmol/L in cases and 12.4±8.1 μmol/L in control subjects (P=.0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile, P=.04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P=.0015) for an increase of 17 μmol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was -.33 compared with -.35 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.

Original languageEnglish
Pages (from-to)250-255
Number of pages6
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume16
Issue number2
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Bilirubin
Coronary Artery Disease
Serum
HDL Cholesterol
Logistic Models
Smoking
Odds Ratio
Angioplasty
Coronary Artery Bypass
LDL Cholesterol
Siblings
Triglycerides
Body Mass Index
Antioxidants
Myocardial Infarction
Regression Analysis
Hypertension

Keywords

  • case-control studies
  • coronary artery disease
  • genetics
  • risk factors
  • serum bilirubin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hopkins, P. N., Wu, L. L., Hunt, S., James, B. C., Michael Vincent, G., & Williams, R. R. (1996). Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(2), 250-255.

Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. / Hopkins, Paul N.; Wu, Lily L.; Hunt, Steven; James, Brent C.; Michael Vincent, G.; Williams, Roger R.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 16, No. 2, 1996, p. 250-255.

Research output: Contribution to journalArticle

Hopkins, PN, Wu, LL, Hunt, S, James, BC, Michael Vincent, G & Williams, RR 1996, 'Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 2, pp. 250-255.
Hopkins, Paul N. ; Wu, Lily L. ; Hunt, Steven ; James, Brent C. ; Michael Vincent, G. ; Williams, Roger R. / Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 1996 ; Vol. 16, No. 2. pp. 250-255.
@article{9f59ebef4b1f438095a5fa6b1ab2b02f,
title = "Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease",
abstract = "Mildly increased serum bilirubin has recently been suggested as aa protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9±6.1 μmol/L in cases and 12.4±8.1 μmol/L in control subjects (P=.0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile, P=.04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P=.0015) for an increase of 17 μmol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was -.33 compared with -.35 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.",
keywords = "case-control studies, coronary artery disease, genetics, risk factors, serum bilirubin",
author = "Hopkins, {Paul N.} and Wu, {Lily L.} and Steven Hunt and James, {Brent C.} and {Michael Vincent}, G. and Williams, {Roger R.}",
year = "1996",
language = "English",
volume = "16",
pages = "250--255",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease

AU - Hopkins, Paul N.

AU - Wu, Lily L.

AU - Hunt, Steven

AU - James, Brent C.

AU - Michael Vincent, G.

AU - Williams, Roger R.

PY - 1996

Y1 - 1996

N2 - Mildly increased serum bilirubin has recently been suggested as aa protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9±6.1 μmol/L in cases and 12.4±8.1 μmol/L in control subjects (P=.0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile, P=.04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P=.0015) for an increase of 17 μmol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was -.33 compared with -.35 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.

AB - Mildly increased serum bilirubin has recently been suggested as aa protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9±6.1 μmol/L in cases and 12.4±8.1 μmol/L in control subjects (P=.0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile, P=.04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P=.0015) for an increase of 17 μmol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was -.33 compared with -.35 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.

KW - case-control studies

KW - coronary artery disease

KW - genetics

KW - risk factors

KW - serum bilirubin

UR - http://www.scopus.com/inward/record.url?scp=0030063426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030063426&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 250

EP - 255

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 2

ER -